companydata.dkcompanydata.dk

Dx-Rx Institute ApS: Financial statements 2019

CVR: 38196537

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

Dx-Rx Institute ApS (CVR 38196537) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 4,620 and a net result of DKK 3,602 compared with DKK -9,758 the year before. Equity in the 2019 report amounted to DKK 49,535. The solvency ratio was 82.6%.

Gross Profit
DKK 4,620
Profit/Loss
DKK 3,602
Equity
DKK 49,535
Total Assets
DKK 59,945
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-5K4K50K0
2018--13K-10K46K0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Dx-Rx Institute ApS: The 2018 annual report is outFeb 19, 2019

Dx-Rx Institute ApS has published its annual report for 2018. Gross profit came to DKK -12,722, and the net result was DKK -9,758.

About Dx-Rx Institute ApS

Dx-Rx Institute ApS was a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2016. The company has been dissolved on 30 May 2023. The company was registered under the industry Anden teknisk rådgivning. According to the 2022 annual report, the company had an average of 1 employee. In 2022, the company reported a gross profit of DKK -16,424 and a net result of DKK -16,470 compared with DKK 2,338 the year before. Equity in the 2022 report amounted to DKK 53,165.

Source: annual report 2022, Danish Business Authority

Other financial years